# NIMH SBIR PHASE I  TOPIC 001-  POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS

> **NIH NIH N43** · GUILD ASSOCIATES, INC. · 2024 · $299,976

## Abstract

This Phase I SBIR contract is in support of the Development of an Integrated Viral Load and Pharmacological Adherence Monitoring Device for Point-of-Care or Self-Monitoring of HIV Infection. Upon the completion of Phase I, a prototype sensor device that can provide a qualitative result to a user regarding their HIV viral load and therapeutic drug concentration will be developed. These results can then be passed on to a physician if needed.

## Key facts

- **NIH application ID:** 11222478
- **Project number:** 75N95024C00026-0-9999-1
- **Recipient organization:** GUILD ASSOCIATES, INC.
- **Principal Investigator:** Matthew Francis Smiechowski
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $299,976
- **Award type:** —
- **Project period:** 2024-09-09 → 2025-09-08

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11222478

## Citation

> US National Institutes of Health, RePORTER application 11222478, NIMH SBIR PHASE I  TOPIC 001-  POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS (75N95024C00026-0-9999-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11222478. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*